Century Therapeutics, Inc.
IPSC
Revenue
771.00k
▼-84.00k▼-9.82%
3 Months ChangeAssets
416.45M
▲67.94M▲19.49%
3 Months ChangeLiabilities
194.34M
▲23.72M▲13.90%
3 Months ChangeFree Cash Flow
-30.79M
▲3.42M▲10.01%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-26
Form 8-K
ID: 0001104659-24-102988
2024-08-08
Form 8-K
ID: 0001104659-24-087013
2024-08-08
Form 10-Q
ID: 0001558370-24-011467
2024-07-08
Form 8-K
ID: 0001104659-24-078322
2024-06-24
Form 8-K
ID: 0001104659-24-074339
2024-06-03
Form 8-K
ID: 0001104659-24-067446
2024-05-09
Form 8-K
ID: 0001104659-24-059124
2024-05-09
Form 10-Q
ID: 0001558370-24-007469
2024-04-11
Form 8-K
ID: 0001104659-24-046373
2024-04-11
Form 8-K
ID: 0001104659-24-046247